OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS
· Real-Time Price · USD
18.28
0.26 (1.44%)
At close: Sep 26, 2025, 3:59 PM
18.28
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT
OrthoPediatrics Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Dec 31, 2020 | Dec 31, 2019 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spine Revenue | 18.52M | 13.66M | 29.32M | 15.63M | 13.68M | 10.2M | 9.66M | 10.3M | 10.89M | 7.07M | 8.04M | 9.98M | 9.42M | 5.98M | 7.17M | 7.27M | 7.66M | 6.64M | 4.89M | 4.9M | 2.69M | 8.29M | 3.3M |
Spine Revenue Growth | +35.55% | -53.39% | +87.50% | +14.27% | +34.10% | +5.58% | -6.21% | -5.41% | +54.03% | -12.09% | -19.38% | +5.92% | +57.46% | -16.58% | -1.29% | -5.11% | +15.39% | +35.68% | -0.12% | +82.38% | -67.60% | +151.17% | n/a |
Sports Medicine And Other Revenue | 905K | 880K | n/a | 1.3M | 1.35M | 1.18M | n/a | 862K | 1.15M | 1.12M | n/a | 1.08M | 939K | 918K | n/a | 996K | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a |
Sports Medicine And Other Revenue Growth | +2.84% | n/a | n/a | -3.93% | +14.32% | n/a | n/a | -25.17% | +2.77% | n/a | n/a | +14.91% | +2.29% | n/a | n/a | -9.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Trauma And Deformity Revenue | 41.66M | 37.87M | n/a | 37.64M | 37.77M | 33.3M | n/a | 28.81M | 27.51M | 23.39M | n/a | 23.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Trauma And Deformity Revenue Growth | +10.00% | n/a | n/a | -0.34% | +13.42% | n/a | n/a | +4.70% | +17.61% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Us Revenue | 12.94M | 11.52M | 21.32M | 11.86M | 11.55M | 10.38M | 9.35M | 10.61M | 9.97M | 7.79M | 8.26M | 8.41M | 7.97M | 5.23M | 5.72M | 4.96M | 4.62M | 2.62M | 1.45M | 2.97M | 3.96M | 4.35M | 4.39M | 3.64M | 3.4M | 3.62M | 3.44M | 7.89M | 2.82M |
Non-Us Revenue Growth | +12.28% | -45.98% | +79.82% | +2.65% | +11.30% | +11.02% | -11.89% | +6.42% | +28.04% | -5.74% | -1.77% | +5.56% | +52.38% | -8.66% | +15.47% | +7.25% | +76.32% | +81.20% | -51.31% | -24.93% | -9.03% | -0.84% | +20.61% | +7.06% | -6.08% | +5.17% | -56.40% | +179.96% | n/a |
United States Revenue | 48.15M | 40.89M | 84.14M | 42.71M | 41.25M | 34.3M | 28.26M | 29.36M | 29.59M | 23.8M | 22.73M | 26.54M | 24.96M | 18.19M | 19.35M | 21.74M | 16.84M | 19.58M | 12.15M | 13.38M | 16.79M | 13.85M | 10.27M | 10.93M | 12.42M | 11.46M | 8.65M | 25.35M | 9.56M |
United States Revenue Growth | +17.74% | -51.40% | +96.99% | +3.55% | +20.24% | +21.38% | -3.74% | -0.77% | +24.32% | +4.70% | -14.34% | +6.33% | +37.23% | -6.02% | -10.96% | +29.09% | -14.01% | +61.23% | -9.25% | -20.26% | +21.21% | +34.88% | -6.06% | -12.01% | +8.40% | +32.42% | -65.87% | +165.31% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 49.55M | 46.85M | 41.22M | 43.05M | 43.92M | 38.9M | 32.03M | 32.09M | 32.82M | 29.88M | 27.5M | 27.04M | 26.98M | 22.93M | 22.03M | 20.9M | 21.96M | 20.99M | 19.47M | 19.06M | 16.2M | 15.45M | 15.58M | 16.04M | 14.18M | 12.16M | 11.1M | 12.03M | 12.28M | 12.1M | 12.1M | 9.12M | 8.72M | 7.57M | 9.03M | 7.18M | 7.1M | 6.96M | 5.78M |
Selling, General, and Administrative Revenue Growth | +5.75% | +13.68% | -4.26% | -1.99% | +12.91% | +21.43% | -0.17% | -2.22% | +9.83% | +8.67% | +1.72% | +0.21% | +17.68% | +4.04% | +5.45% | -4.86% | +4.64% | +7.81% | +2.15% | +17.68% | +4.87% | -0.84% | -2.88% | +13.14% | +16.58% | +9.51% | -7.68% | -2.02% | +1.48% | +0.01% | +32.62% | +4.58% | +15.28% | -16.21% | +25.76% | +1.08% | +2.00% | +20.49% | n/a |
Research and Development Revenue | 2.16M | 2.35M | 2.92M | 2.58M | 2.54M | 3M | 2.75M | 2.39M | 2.79M | 2.27M | 2.03M | 2.21M | 1.75M | 2.03M | 1.61M | 1.3M | 1.32M | 1.31M | 2.05M | 1.08M | 881K | 1.26M | 1.91M | 1.4M | 1.23M | 1.21M | 1.28M | 1.12M | 1.11M | 1.22M | 941K | 1.13M | 668K | 687K | 624K | 501K | 589K | 507K | 479K |
Research and Development Revenue Growth | -8.17% | -19.38% | +13.15% | +1.34% | -15.18% | +9.14% | +15.08% | -14.51% | +23.00% | +11.60% | -7.80% | +26.27% | -13.81% | +26.06% | +23.50% | -1.74% | +1.30% | -36.20% | +90.34% | +22.25% | -30.36% | -33.60% | +36.46% | +13.13% | +1.73% | -5.01% | +13.81% | +0.63% | -8.46% | +29.44% | -16.50% | +68.71% | -2.77% | +10.10% | +24.55% | -14.94% | +16.17% | +5.85% | n/a |
Sales and Marketing Revenue | 19.1M | 16.57M | 16.78M | 16.75M | 16.59M | 14.17M | 12.44M | 13.94M | 13.16M | 12.22M | 10.95M | 11.92M | 12.43M | 9.76M | 9.99M | 9.86M | 10.88M | 8.95M | 9.43M | 9.24M | 5.62M | 7.56M | 8.36M | 8.77M | 7.61M | 6.55M | 6.56M | 7.15M | 6.78M | 6.08M | 5.41M | 5.63M | 5.3M | 4.19M | 4.26M | 4.29M | 4.34M | 3.77M | 3.21M |
Sales and Marketing Revenue Growth | +15.27% | -1.26% | +0.20% | +0.95% | +17.11% | +13.91% | -10.78% | +5.90% | +7.77% | +11.61% | -8.17% | -4.12% | +27.39% | -2.28% | +1.26% | -9.32% | +21.53% | -5.13% | +2.12% | +64.36% | -25.70% | -9.52% | -4.69% | +15.32% | +16.18% | -0.17% | -8.28% | +5.52% | +11.47% | +12.47% | -4.05% | +6.30% | +26.41% | -1.60% | -0.68% | -1.08% | +15.01% | +17.56% | n/a |